Search

everythinglearnresearchcommunity

for

Search:↓

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Talquetamab may cause hair loss and skin issues.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Tetrahydroxystilbene Glucoside may help prevent hair loss by blocking certain pathways that lead to cell death.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

N-acetylcysteine and memantine are recommended as safe and effective treatments for trichotillomania.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.